99% Savings - Buy Just @1 Rs X
Cilaspen is a commercial drug that is prescribed in the form of Injection. Secondary and off-label uses of Cilaspen have also been mentioned below.
The right dosage of Cilaspen depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Cilaspen side effects, there are can be others also. These have been listed below. Such side effects of Cilaspen normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Cilaspen's effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Cilaspen related warnings talks about Cilaspen's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Kidney Disease, Kidney Disease must refrain from the use of Cilaspen since this can cause severe adverse effects. Other contraindications of Cilaspen have been discussed in the sections ahead.
Drug reaction of Cilaspen with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Cilaspen, it is important to know that it is safe while driving, and is habit-forming.
Cilaspen is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Cilaspen safe for pregnant women?
Cilaspen can have harmful effects in pregnant women. If you experience any discomfort after using Cilaspen, then discontinue the use and take your doctor's advice.
Is the use of Cilaspen safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Cilaspen. Immediately discontinue Cilaspen if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Cilaspen on the Kidneys?
There can be some harmful effects on your kidneys after taking Cilaspen. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Cilaspen on the Liver?
There may be an adverse effect on the liver after taking Cilaspen. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Cilaspen on the Heart?
Side effects of Cilaspen rarely affect the heart.
Cilaspen should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Cilaspen unless your doctor advises you to do so -
Is this Cilaspen habit forming or addictive?
Forming a habit of Cilaspen has not been reported.
Interaction between Food and Cilaspen
When consumed with certain foods, Cilaspen may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Cilaspen
Consuming Cilaspen with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Primaxin® (imipenem and cilastatin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 731
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 676-678